The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2020). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R21AI126361-02
Multiplexed quantification of circulating peptidomic signatures for EBOLA early diagnosis
National Institutes of Health
Grant: 5R01AI113725-04
Real-time Detection of Active TB in HIV Exposed Children on CustomizedNanotrap
National Institutes of Health
Grant: 1R35HL139930-01
CD4_T-cell_Immunity_in_the_Lung
National Institutes of Health
Grant: 5R21EB026347-02
Mobile based Nanoplasmonic Quantification of Mtb-derived Exosomes in Serum for Pediatric TB diagnosis
National Institutes of Health
Grant: 7R01HD090927-04
Direct quantitation of the circulating Mtb-peptidome for pediatric TB management
National Institutes of Health
Grant: 5R01AI122932-03
Quantification of Circulating Antigens for Pediatric TB Diagnosis andTreatment Monitoring
Fields of Study
Keywords
Sustainable Development Goals